2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 12, 2024 -- During 2004 to 2021, there was an increase in distant-stage breast cancer incidence rates at presentation, according to a study published online Dec. 10 in Radiology.
R. Edward Hendrick, Ph.D., and Debra L. Monticciolo, M.D., from the University of Colorado School of Medicine in Aurora, examined trends in distant-stage breast cancer incidence using the latest data from the Surveillance, Epidemiology, and End Results database. Stage-specific breast cancer incidence rates were analyzed from January 2004 to December 2021 in a retrospective study of 71 to 80 million women annually.
The researchers found a significant increase in distant-stage breast cancer incidence rates at presentation for U.S. women overall, with an annual percentage change (APC) of 1.16 percent during 2004 to 2021. For women aged 20 to 39 years and for women aged 75 years or older, distant-stage disease increased consistently (APCs, 2.91 and 1.44 percent, respectively). For women aged 40 to 74 years, the distant-stage breast cancer incidence rates increased with APCs of 2.10 and 2.73 percent during 2004 to 2010 and 2018 to 2021, respectively. The COVID-19-linked interruption of care in 2020 affected distant-stage breast cancer detection, especially among older women from racial and ethnic minority groups. During 2004 to 2021, the incidence of distant-stage breast cancer increased for Asian, Black, and Hispanic women (APCs, 2.90, 0.86, and 1.56 percent, respectively), and during 2004 to 2019, the incidence increased for Native American women (APC, 3.86 percent).
"Much work is needed to improve early detection and ensure that all women have sustained access to care," the authors write.
One author disclosed ties to the medical device industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-13 06:00
Read more

- American Stroke Association, Feb. 5-7
- Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
- Highway Exhaust Linked to Depression in Women
- Multicomponent Prehabilitation Beneficial for Surgical Patients
- Chronic Medical Conditions Take Toll on Employees
- For Less Severe Child Peanut Allergies, Small Doses of Peanut Butter May Help
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions